| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Latigo Biotherapeutics, Inc.
13G/A
Amendment 1
LTGO · 517954103
|
4.8% |
11/6/2026
Event 9/3/2026
|
|||
| AI Biotechnology LLC | 4.8% | ||||
| Access Industries Holdings LLC | 4.8% | ||||
| Access Industries Management, LLC | 4.8% | ||||
| Len Blavatnik | 4.8% | ||||
|
Latigo Biotherapeutics, Inc.
13G
LTGO · 517954103
|
5.0% |
8/18/2026
Event 8/11/2026
|
|||
| AI Biotechnology LLC | 5.0% | ||||
| Access Industries Holdings LLC | 5.0% | ||||
| Access Industries Management, LLC | 5.0% | ||||
| Len Blavatnik | 5.0% | ||||
|
Yarrow Bioscience, Inc.
13D/A
Amendment 1
YARW · 92941V407
|
6.0% |
7/29/2026
Event 7/27/2026
|
|||
| AI Biotechnology LLC | 6.0% | ||||
| Access Industries Holdings LLC | 6.0% | ||||
| Access Industries Management, LLC | 6.0% | ||||
| Len Blavatnik | 6.0% | ||||
|
OnKure Therapeutics, Inc.
13D
OKUR · 68277Q105
|
20.0% |
4/7/2026
Event 3/31/2026
|
|||
| AI Biotechnology LLC | 20.0% | ||||
| Access Industries Holdings LLC | 20.0% | ||||
| Access Industries Management, LLC | 20.0% | ||||
| Len Blavatnik | 20.0% | ||||
|
Zura Bio Limited
13D/A
Amendment 1
ZURA · G9TY5A101
|
18.2% |
3/2/2026
Event 2/26/2026
|
|||
| AI Biotechnology LLC | 18.2% | ||||
| Access Industries Holdings LLC | 18.2% | ||||
| Access Industries Management, LLC | 18.2% | ||||
| Len Blavatnik | 18.2% | ||||
|
Zura Bio Limited
13D
ZURA · G9TY5A101
|
19.9% |
5/28/2025
Event 5/21/2025
|
|||
| AI Biotechnology LLC | 19.9% | ||||
| Access Industries Holdings LLC | 19.9% | ||||
| Access Industries Management, LLC | 19.9% | ||||
| Len Blavatnik | 19.9% | ||||
|
Surrozen, Inc.
13G
SRZN · 86889P208
|
9.9% |
3/31/2025
Event 3/24/2025
|
|||
| AI Biotechnology LLC | 9.9% | ||||
| Access Industries Holdings LLC | 9.9% | ||||
| Access Industries Management, LLC | 9.9% | ||||
| Len Blavatnik | 9.9% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.